Close Menu
    Wall Street

    FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.


    FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.

    https://www.cnbc.com/2024/07/02/fda-approves-eli-lilly-alzheimers-drug-donanemab.html?__source=iosappshare%7Ccom.apple.UIKit.activity.CopyToPasteboard

    Posted by ishiboy

    View 11 Comments

    11 Comments

    1. ulumulu23 on

      That treatment will probably cost your firstborn child in the US so bullish af ![img](emote|t5_2th52|4271)![img](emote|t5_2th52|4267)

    4. CamxThexMan3 on

      stock is down … this tells me the drug is probably useless. big catalyst but no price movement is sketchy.

    5. wefarrell on

      Currently the US has this huge problem where the older generations control a disproportionate amount of wealth and it’s going to have to go somewhere as they die.

      I’m glad big pharma is stepping up.

    7. IhavebeenShot on

      Wow they’re pushing it out into the market even though their own data showed it likely doesn’t work?

      Shit Its looking like the time to cure Alzheimer’s is looking to be 20-30 years before you even think about it with and by screening for it then taking steps and treatments and sadly right now by the time you start showing any physical or mental symptoms this drug likely ain’t going to do dick other then maybe slow down the runaway process going on in the patient’s mind.

      But they clearly need to recoup their money they spent to make this drug so their going to sell False hope to some very desperate people probably using Medicare to cover the cost even though sadly it likely won’t help them.

    Leave A Reply
    Share via